Hikma Pharmaceuticals PLC (HIK)

Industry Drug Manufacturers - Specialty & Generic

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

1,251.00p

Buy

1,252.00p

arrow-down-65.00p (-4.95%)

Prices updated at 02 Mar 2026, 17:11 GMT

Prices minimum 15 mins delay

Prices in GBX

Hikma Pharmaceuticals PLC develops, manufactures and markets a broad range of branded and non-branded generic pharmaceutical products across the US, the MENA region, and Europe.

FTSE All-Share

-1.22%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

In the news

Sharecast service unavailable

Press releases

02 Mar 2026

27 Feb 2026

26 Feb 2026

04 Feb 2026

03 Feb 2026

19 Dec 2025

15 Dec 2025

Key dates

	Forecast date
Final results	Feb 2027
Annual general meeting	Apr 2026
Annual report	Mar 2026
Half yearly results	-

	Previous date
Final results	Feb 2026
Half yearly results	Aug 2025
Annual general meeting	Apr 2025
Annual report	Mar 2025

Company reports

31 Dec 2023

Annual Report

31 Dec 2025

Quarterly Report

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.